Supplementary Figure S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
Authors:
- Srivandana AkshintalaSASrivandana Akshintala
- R. Taylor SundbyRSR. Taylor Sundby
- Donna BernsteinDBDonna Bernstein
- John W. GlodJGJohn W. Glod
- Rosandra N. KaplanRKRosandra N. Kaplan
- Marielle E. YoheMYMarielle E. Yohe
- Andrea M. GrossAGAndrea M. Gross
- Joanne DerdakJDJoanne Derdak
- Haiyan LeiHLHaiyan Lei
- Alexander PanAPAlexander Pan
- Eva DombiEDEva Dombi
- Isabel Palacio-YanceIPIsabel Palacio-Yance
Open Access
- 25 November 2025
- other
- Published by American Association for Cancer Research (AACR)